tirzepatide semaglutide head to head vs Tirzepatide: Complete Comparison (2026) Semaglutide vs Tirzepatide: Effectiveness, Side

Continue reading After 6 months of treatment, use of GLP-1 medications was associated with: Increased risk of androgenic alopecia Increased risk of non-scarring hair loss No significant change to the risk of telogen effluvium No significant change to the risk of alopecia areata After 12 months of treatment, use of GLP-1 medications was associated with: Increased risk of androgenic alopecia Increased risk of non-scarring hair loss Increased risk of telogen effluvium No significant change to the risk of alopecia areata Interestingly, no increased risk of alopecia areata was found, given that GLP-1 medications like semaglutide have been reported to be linked to this condition in case studies

This episode of Breathing Room is supported Eli Lilly and Company

Ipamorelin is a growth hormone secretagogue receptor agonist that has been shown in animal studies to have potent and specific effects on GH secretion while having very limited side effects [5]

Elevated prenatal anti-Mllerian hormone reprograms the fetus and inducespolycystic ovary syndrome in adulthood

None of this is an argument against GLP-1 therapy